U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"We are probably nearing the limit of all we can know about astronomy."

Simon Newcomb, astronomer ; 1888

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: Matrix Pharmaceutical, Inc.


Location: Fremont, CA
No. of patents: 6

NumberTitleIssue Date
6224883Process and composition for therapeutic cisplatin (CDDP)
An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The...
05/01/2001
6077545Process and composition for therapeutic cisplatin (CDDP)
An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The...
06/20/2000
5968355Apparatus for aseptic vortex flow concentration
An apparatus is provided having a rotor inside a membrane for the aseptic vortex flow concentration of a liquid or semisolid dispersion which has a shed-resistant bearing interface so that unwanted bearing material does not contaminate the substances, e.g...
10/19/1999
5925246Apparatus for aseptic vortex flow concentration
An apparatus is provided having a rotor inside a membrane for the aseptic vortex flow concentration of a liquid or semisolid dispersion which has a shed-resistant bearing interface so that unwanted bearing material does not contaminate the substances, e.g...
07/20/1999
5874402Use of cell membrane permeants in the treatment of cellular proliferative diseases
Methods are provided for the treatment of a host suffering from a cellular proliferative disease through administration of a chemotherapeutic agent in conjunction with a cell membrane permeant. Optionally, the cell membrane permeant and/or chemotherapeuti...
02/23/1999
5874006Aseptic collagen concentration process
A process for the aseptic concentration of collagen from about 0.25% (w/w) suspensions to gels of 15% using vortex flow filtration with a variety of membrane types--ultrafiltration and microfiltration and polymeric and stainless steel is provided. The res...
02/23/1999
 
Sign InRegister
Username  
Password   
forgot password?